196 related articles for article (PubMed ID: 21859942)
1. Daptomycin, fosfomycin, or both for treatment of methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model.
Poeppl W; Tobudic S; Lingscheid T; Plasenzotti R; Kozakowski N; Lagler H; Georgopoulos A; Burgmann H
Antimicrob Agents Chemother; 2011 Nov; 55(11):4999-5003. PubMed ID: 21859942
[TBL] [Abstract][Full Text] [Related]
2. Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats.
Lingscheid T; Poeppl W; Bernitzky D; Veletzky L; Kussmann M; Plasenzotti R; Burgmann H
Antimicrob Agents Chemother; 2015 Feb; 59(2):859-63. PubMed ID: 25403675
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of fosfomycin in experimental osteomyelitis due to methicillin-resistant Staphylococcus aureus.
Poeppl W; Tobudic S; Lingscheid T; Plasenzotti R; Kozakowski N; Georgopoulos A; Burgmann H
Antimicrob Agents Chemother; 2011 Feb; 55(2):931-3. PubMed ID: 21098253
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of fosfomycin compared to vancomycin in treatment of implant-associated chronic methicillin-resistant Staphylococcus aureus osteomyelitis in rats.
Poeppl W; Lingscheid T; Bernitzky D; Schwarze UY; Donath O; Perkmann T; Kozakowski N; Plasenzotti R; Reznicek G; Burgmann H
Antimicrob Agents Chemother; 2014 Sep; 58(9):5111-6. PubMed ID: 24936591
[TBL] [Abstract][Full Text] [Related]
5. Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
Karau MJ; Schmidt-Malan SM; Yan Q; Greenwood-Quaintance KE; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358593
[TBL] [Abstract][Full Text] [Related]
6. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.
Mihailescu R; Furustrand Tafin U; Corvec S; Oliva A; Betrisey B; Borens O; Trampuz A
Antimicrob Agents Chemother; 2014 May; 58(5):2547-53. PubMed ID: 24550327
[TBL] [Abstract][Full Text] [Related]
7. The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis.
García-de-la-Mària C; Gasch O; García-Gonzalez J; Soy D; Shaw E; Ambrosioni J; Almela M; Pericàs JM; Tellez A; Falces C; Hernandez-Meneses M; Sandoval E; Quintana E; Vidal B; Tolosana JM; Fuster D; Llopis J; Pujol M; Moreno A; Marco F; Miró JM
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610194
[TBL] [Abstract][Full Text] [Related]
8. High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.
Miró JM; Entenza JM; Del Río A; Velasco M; Castañeda X; Garcia de la Mària C; Giddey M; Armero Y; Pericàs JM; Cervera C; Mestres CA; Almela M; Falces C; Marco F; Moreillon P; Moreno A;
Antimicrob Agents Chemother; 2012 Aug; 56(8):4511-5. PubMed ID: 22644033
[TBL] [Abstract][Full Text] [Related]
9. Imipenem plus Fosfomycin as Salvage Therapy for Vertebral Osteomyelitis.
Nakamura I; Yamaguchi T; Aoki K; Miura Y; Sato S; Fujita H; Watanabe H
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 32958715
[TBL] [Abstract][Full Text] [Related]
10. Native valve endocarditis caused by Corynebacterium striatum with heterogeneous high-level daptomycin resistance: collateral damage from daptomycin therapy?
Tran TT; Jaijakul S; Lewis CT; Diaz L; Panesso D; Kaplan HB; Murray BE; Wanger A; Arias CA
Antimicrob Agents Chemother; 2012 Jun; 56(6):3461-4. PubMed ID: 22450978
[TBL] [Abstract][Full Text] [Related]
11. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
Mader JT; Adams K
Antimicrob Agents Chemother; 1989 May; 33(5):689-92. PubMed ID: 2546488
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial.
Shaw E; Miró JM; Puig-Asensio M; Pigrau C; Barcenilla F; Murillas J; Garcia-Pardo G; Espejo E; Padilla B; Garcia-Reyne A; Pasquau J; Rodriguez-Baño J; López-Contreras J; Montero M; de la Calle C; Pintado V; Calbo E; Gasch O; Montejo M; Salavert M; Garcia-Pais MJ; Carratalà J; Pujol M; ; ;
BMJ Open; 2015 Mar; 5(3):e006723. PubMed ID: 25762232
[TBL] [Abstract][Full Text] [Related]
15. Fosfomycin-daptomycin and other fosfomycin combinations as alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Garrigós C; Murillo O; Lora-Tamayo J; Verdaguer R; Tubau F; Cabellos C; Cabo J; Ariza J
Antimicrob Agents Chemother; 2013 Jan; 57(1):606-10. PubMed ID: 23089756
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
[TBL] [Abstract][Full Text] [Related]
17. Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
Karau MJ; Schmidt-Malan SM; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33722889
[No Abstract] [Full Text] [Related]
18. Synergy Mechanisms of Daptomycin-Fosfomycin Combinations in Daptomycin-Susceptible and -Resistant Methicillin-Resistant Staphylococcus aureus:
Mishra NN; Lew C; Abdelhady W; Lapitan CK; Proctor RA; Rose WE; Bayer AS
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0164921. PubMed ID: 34694870
[TBL] [Abstract][Full Text] [Related]
19. Vertebral osteomyelitis caused by vancomycin-tolerant methicillin-resistant Staphylococcus aureus bacteremia: Experience with teicoplanin plus fosfomycin combination therapy.
Lee WS; Chen YC; Chen HP; Chen TH; Cheng CY
J Microbiol Immunol Infect; 2016 Aug; 49(4):600-3. PubMed ID: 24269007
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.
Pujol M; Miró JM; Shaw E; Aguado JM; San-Juan R; Puig-Asensio M; Pigrau C; Calbo E; Montejo M; Rodriguez-Álvarez R; Garcia-Pais MJ; Pintado V; Escudero-Sánchez R; Lopez-Contreras J; Morata L; Montero M; Andrés M; Pasquau J; Arenas MD; Padilla B; Murillas J; Jover-Sáenz A; López-Cortes LE; García-Pardo G; Gasch O; Videla S; Hereu P; Tebé C; Pallarès N; Sanllorente M; Domínguez MÁ; Càmara J; Ferrer A; Padullés A; Cuervo G; Carratalà J;
Clin Infect Dis; 2021 May; 72(9):1517-1525. PubMed ID: 32725216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
